Written by Keen Meds  ·  Reviewed by Licensed Clinical Providers  ·  March 1, 2026

Key Insight: Weeks 1-4 of TRT: testosterone levels reach steady state (spray), but full clinical benefit requires 3-6 months. Early signs -- slightly improved sleep and libido -- may appear by week 3-4 in some men.

> Weeks 1-4 of TRT: testosterone levels reach steady state (spray), but full clinical benefit requires 3-6 months. Early signs -- slightly improved sleep and libido -- may appear by week 3-4 in some men.

Medically reviewed by licensed clinical providers · March 2026

Starting testosterone replacement therapy involves a gap between what men expect to feel in the first month and what they are likely to actually experience. Much of the content circulating online emphasizes dramatic early results -- energy surges, rapid body changes, transformative shifts in the first few weeks. The clinical reality is considerably more measured. Month one is about establishing stable hormone levels, not delivering peak clinical effects. Understanding what is and is not likely to happen in weeks one through four helps men stay the course, monitor appropriately, and avoid the most common mistake: stopping too soon.

How Testosterone Spray Reaches Steady State

For men using Testosterone Spray Rx via Hypospray® -- a transdermal on-skin spray applied daily -- the pharmacokinetic timeline is different from injections. Transdermal delivery is continuous and absorptive: each application adds to a gradually rising steady-state level. Because there is no single large depot injection, levels rise predictably and reach steady state within the first few days to one week of consistent daily use. By the end of week one, most men on transdermal spray have testosterone levels that reflect their therapeutic dose -- not a ramp-up approximation, but an actual steady state.

This is an advantage of transdermal delivery: the hormone environment stabilizes quickly. What takes longer -- weeks to months -- is the tissue-level adaptation that produces the clinical effects patients are looking for.

Weeks 1 to 2: Levels Rising, System Calibrating

Most men report very little in the first one to two weeks. This is normal and expected. Testosterone levels may be in or near the therapeutic range, but the tissue systems that respond to those levels have not had enough sustained exposure to show measurable change.

Some men describe a subtle shift in alertness or mood in the first two weeks -- a sense that something is slightly different without being able to name what. Others notice nothing. Both responses are normal. The absence of obvious early effects is not a sign that the therapy is not working.

One thing that occasionally changes in the first two weeks: sleep. Some men report marginally improved sleep quality -- fewer awakenings, slightly better morning energy. This is not universal, but it is among the earlier subjective signals that some men notice. Whether this reflects testosterone's direct effect or a subtle improvement in REM architecture is not fully established, but it is clinically plausible given testosterone's role in sleep regulation.

Weeks 2 to 3: Early Signals in Some Men

By the end of week two and into week three, some men begin noticing incremental changes in one or two domains. These are not dramatic -- they are more in the category of "slightly better than last week" than "clearly different from last month."

Libido is the most commonly reported early indicator. Some men notice slightly increased spontaneous sexual interest or that their interest responds more readily to appropriate stimuli. Morning erections may return more consistently in men who had experienced their absence. These are early signals, not the full effect -- they indicate the therapy is beginning to have an impact on androgen-sensitive neural pathways, which respond relatively quickly compared to muscle or metabolic tissue.

Energy is the other domain where some men notice early, subtle changes. A marginal reduction in mid-afternoon fatigue, a slightly improved sense of motivation in the morning, or less mental sluggishness after meals. These effects are genuinely subtle at weeks 2 to 3 -- the kind of change you might notice and then wonder if it was real.

Weeks 3 to 4: The First Clearer Indicators

For men who respond to TRT on an early timeline, weeks 3 to 4 tend to produce the first changes that feel clearly different rather than possibly different. Libido is often the clearest of these. Sexual interest, morning erections, and responsiveness to arousal are all androgen-sensitive and represent the earliest consistent clinical signal in the TRT literature.

Energy may become more clearly perceptible by week 4 in some men -- a sense of better stamina through the workday, less need for stimulants, or improved motivation for physical activity. Mood can begin shifting as well: some men describe less irritability or a slightly improved baseline disposition. These effects are more variable than libido -- some men experience them clearly by week 4, others not until months two or three.

What Will Not Change in Month One

Body composition will not change in month one. Lean mass gains and visible changes in fat distribution require 3 to 6 months of sustained therapeutic-range dosing combined with appropriate nutrition and training. A man who expects visible muscle changes at four weeks on TRT will be disappointed. This is biology, not failure.

Significant strength gains are similarly a longer-term outcome. The mechanism -- increased muscle protein synthesis over time -- is real, but it requires months to manifest at a detectable level.

Cognitive effects, if they occur, typically take 6 or more weeks to appear, and for some men they develop over several months. Men who start TRT primarily for cognitive symptoms (brain fog, poor concentration) should expect these to be among the last benefits to emerge, if they emerge at all -- cognitive effects of TRT are more variable in the research literature than sexual or energy effects.

Why Stopping Early Is the Most Common Mistake

The most common pattern that limits TRT outcomes is discontinuation between weeks 3 and 8, when expected benefits have not arrived on the anticipated schedule. In many cases, these men would have begun experiencing clinical benefit by months 2 to 3 -- they simply stopped before reaching the window where TRT begins to work for their symptom profile.

The 3-month clinical checkpoint exists precisely to manage this period. At 3 months, a blood panel confirms whether levels are therapeutic, whether dose adjustment is needed, and whether the clinical picture warrants continuing unchanged or modifying the approach. Stopping at week 6 because "nothing happened yet" bypasses this checkpoint and the dose optimization it enables.

What to Track During Month One

A simple log helps contextualize month one. Men starting TRT may benefit from noting (roughly weekly):

  • Sleep quality: hours, awakening frequency, morning energy
  • Libido: spontaneous interest, frequency, intensity
  • Morning erections: frequency (none, occasional, regular)
  • Daytime energy: subjective rating, afternoon fatigue
  • Mood: general disposition, irritability, motivation

This is not a rigorous clinical instrument -- it is a personal baseline. At the 3-month mark, comparing your current state to your week-one log is often the clearest way to see incremental improvement that is otherwise hard to perceive in real time.

Side Effects to Watch for in Month One

TRT is generally well-tolerated, but a few side effects are most likely to appear in the first month:

Acne: The most common early side effect. Androgen-stimulated sebaceous glands respond quickly. Mild facial or back acne affects some men in the first 4 to 8 weeks. It often improves as levels stabilize. Persistent or severe acne should be discussed with your provider.

Testicular size reduction: Exogenous testosterone suppresses LH and FSH -- the pituitary signals that drive testicular testosterone production. When LH drops, the testes reduce their output and may reduce modestly in size. This is expected, not harmful, and not permanent -- it reflects HPG axis suppression, which is a normal and anticipated consequence of exogenous testosterone use.

Skin site reactions: With transdermal spray, some men experience mild local skin irritation at the application site -- redness, mild itching. This typically resolves within a few days and can often be managed by rotating application sites.

Hematocrit elevation (polycythemia) is a real TRT risk but does not manifest meaningfully in month one. This is why the 3-month panel is the appropriate time to check it, not an emergency room visit at week two.

Practical Tips for Transdermal Spray Application

Consistent application technique matters for stable levels:

  • Apply to clean, dry skin -- ideally inner arms, shoulders, or upper torso
  • Allow the application site to dry completely before covering with clothing
  • Apply at the same time each day to maintain consistent absorption patterns
  • Avoid showering or swimming for at least 2 hours after application
  • Wash hands after application and avoid skin-to-skin contact with partners at the application site

Inconsistent application -- missed days, wet skin, highly variable application sites -- introduces level variability that can make it harder to assess whether the dose is working appropriately.

Frequently Asked Questions

I'm at week 3 and haven't noticed anything. Should I stop?
No. Week 3 is within the normal window before most clinical effects develop. Libido and energy changes typically emerge between weeks 3 and 6, with clearer changes developing through months 2 and 3. The absence of dramatic effects at week 3 is the expected experience for most men -- not a signal of treatment failure. Continue until your 3-month blood panel confirms whether your levels are therapeutic.

Is it normal for my testicles to be smaller since starting TRT?
A modest reduction in testicular size is a common and expected effect of exogenous testosterone. It reflects suppression of LH and FSH, which reduces intra-testicular testosterone production and spermatogenesis. The change is not permanent and does not affect sexual function. If you have fertility concerns, discuss HPG axis management options with your provider before or at the start of therapy.

When should I contact my provider versus waiting for the 3-month check?
Contact your provider before the 3-month check if you experience: severe acne or skin reactions, signs of elevated hematocrit (headaches, flushing, leg pain or swelling), significant PSA-related urinary symptoms, or mood changes that concern you. Mild acne, subtle sleep or libido shifts, and the absence of obvious effects in week one to three do not require early contact -- these are within the expected range of month-one experience.

The First Month Is the Beginning of a 3-Month Process

What happens in weeks 1 to 4 of TRT sets the stage for the clinical evaluation at month 3. Stable levels, consistent application, and a symptom log give you and your provider the information needed to make the therapy work well.

Keen Meds connects you with a licensed clinical team for a telehealth consultation and lab review. If your testosterone is clinically low, you receive a prescription for Testosterone Spray Rx -- delivered via Hypospray®, Keen's needle-free transdermal spray platform.

Start your Keen Testosterone Spray Program →

Medically reviewed by Licensed Clinical Providers · March 2026

Related reading: